SE503227C2 - Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma - Google Patents

Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma

Info

Publication number
SE503227C2
SE503227C2 SE8804688A SE8804688A SE503227C2 SE 503227 C2 SE503227 C2 SE 503227C2 SE 8804688 A SE8804688 A SE 8804688A SE 8804688 A SE8804688 A SE 8804688A SE 503227 C2 SE503227 C2 SE 503227C2
Authority
SE
Sweden
Prior art keywords
general formula
mol
nitrogen atom
same
alkyl
Prior art date
Application number
SE8804688A
Other languages
English (en)
Swedish (sv)
Other versions
SE8804688L (sv
SE8804688D0 (sv
Inventor
Zoltan Budai
Lujza Petocz
Tibor Mezei
Nee Kiszelly Eniko Szirt
Nee Hegedues Maria Szecsey
Gabor Gigler
Nee Esess Klara Reiter
Nee Konya Aranka Lay
Eva Furdyga
Istvan Gyertyan
Istvan Gacsalyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8804688D0 publication Critical patent/SE8804688D0/xx
Publication of SE8804688L publication Critical patent/SE8804688L/xx
Publication of SE503227C2 publication Critical patent/SE503227C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
SE8804688A 1987-12-31 1988-12-29 Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma SE503227C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876171A HU202195B (en) 1987-12-31 1987-12-31 Process for producing new substituted styrene derivatives and medical compositions comprising such compounds

Publications (3)

Publication Number Publication Date
SE8804688D0 SE8804688D0 (sv) 1988-12-29
SE8804688L SE8804688L (sv) 1989-07-01
SE503227C2 true SE503227C2 (sv) 1996-04-22

Family

ID=10971303

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8804688A SE503227C2 (sv) 1987-12-31 1988-12-29 Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma

Country Status (24)

Country Link
US (1) US4939142A (zh)
JP (1) JPH0222258A (zh)
CN (1) CN1022103C (zh)
AT (1) AT396362B (zh)
AU (1) AU610966B2 (zh)
BE (1) BE1004906A3 (zh)
CA (1) CA1326484C (zh)
CH (1) CH678322A5 (zh)
CS (1) CS274494B2 (zh)
DD (1) DD287491A5 (zh)
DE (1) DE3900028A1 (zh)
DK (1) DK728888A (zh)
ES (1) ES2024077A6 (zh)
FI (1) FI90867C (zh)
FR (1) FR2625501B1 (zh)
GB (1) GB2213481B (zh)
GR (1) GR1002384B (zh)
HU (1) HU202195B (zh)
IL (1) IL88827A (zh)
IT (1) IT1227919B (zh)
NL (1) NL8803221A (zh)
PL (1) PL154358B1 (zh)
SE (1) SE503227C2 (zh)
YU (1) YU47605B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
AU2001250820A1 (en) * 2000-03-13 2001-09-24 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclohexene derivatives useful as antagonists of the motilin receptor
US7415634B2 (en) * 2004-03-25 2008-08-19 International Business Machines Corporation Method for fast system recovery via degraded reboot
JP4912281B2 (ja) * 2007-11-27 2012-04-11 三菱電機株式会社 回路基板のはんだ付け用治具
US20100021276A1 (en) * 2008-07-24 2010-01-28 James Baughman Tilt loading platform for wheeled vehicles
EP3282845A4 (en) * 2015-04-15 2018-04-18 Valent Biosciences Llc (s)-2'-vinyl-abscisic acid derivatives
WO2019084476A1 (en) * 2017-10-26 2019-05-02 University Of Tennessee Research Foundation ANTAGONISTS OF FIBROBLAST GROWTH FACTOR 23 AND RELATED COMPOSITIONS AND METHODS
CN110305054B (zh) * 2019-07-19 2021-03-02 哈尔滨工业大学 一种双取代苯乙烯类衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493222A (en) * 1976-01-27 1977-11-30 Egyt Gyogyszervegyeszeti Gyar Cycloalkanone oxime ethers and process for the preparation thereof
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU188250B (en) * 1983-02-08 1986-03-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing of basical oxim-ethers
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
PL154358B1 (en) 1991-08-30
ATA320788A (de) 1992-12-15
DK728888D0 (da) 1988-12-29
CN1022103C (zh) 1993-09-15
GB8830417D0 (en) 1989-03-01
DE3900028A1 (de) 1989-07-13
HUT48867A (en) 1989-07-28
YU47605B (sh) 1995-10-24
AU2762788A (en) 1989-07-06
CN1034709A (zh) 1989-08-16
IT8823180A0 (it) 1988-12-30
SE8804688L (sv) 1989-07-01
CS900788A2 (en) 1990-09-12
PL276892A1 (en) 1989-08-21
NL8803221A (nl) 1989-07-17
FR2625501A1 (fr) 1989-07-07
IL88827A (en) 1993-01-14
JPH0222258A (ja) 1990-01-25
AU610966B2 (en) 1991-05-30
US4939142A (en) 1990-07-03
FR2625501B1 (fr) 1993-05-21
FI886066A (fi) 1989-07-01
GB2213481B (en) 1991-07-17
SE8804688D0 (sv) 1988-12-29
GR1002384B (el) 1996-07-03
AT396362B (de) 1993-08-25
YU238288A (en) 1990-06-30
CS274494B2 (en) 1991-04-11
DD287491A5 (de) 1991-02-28
IT1227919B (it) 1991-05-14
IL88827A0 (en) 1989-07-31
BE1004906A3 (fr) 1993-02-23
FI90867B (fi) 1993-12-31
DK728888A (da) 1989-07-01
GR880100869A (el) 1994-03-31
FI90867C (fi) 1994-04-11
GB2213481A (en) 1989-08-16
CH678322A5 (zh) 1991-08-30
CA1326484C (en) 1994-01-25
HU202195B (en) 1991-02-28
ES2024077A6 (es) 1992-02-16

Similar Documents

Publication Publication Date Title
US7642277B2 (en) Non-nucleoside reverse transcriptase inhibitors
US5395839A (en) Imidazopyridine derivatives and their use
US20040186127A1 (en) Novel deazapurines and uses thereof
JPH09504004A (ja) ５ｈｔ１ｄレセプター拮抗薬用アミドおよび尿素誘導体
HU207988B (en) Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
EP0109562A1 (en) Succinimide derivatives and their production
CZ277925B6 (en) Chemotherapeutic agent
US3974158A (en) 2-(Substituted anilino)methylmorpholines
JPH09512528A (ja) バソプレッシン拮抗物質としてのベンズアミド誘導体
EP0937715B1 (en) Tetrahydrobenzindole compounds
SE503227C2 (sv) Substituerade styrenderivat, förfarande för framställning av dessa samt farmaceutiska kompositioner innehållande desamma
EP1608635A1 (en) Phenyl sulfone derivatives and their use in the treatment of cns disorders
DE69002079T2 (de) 5,11-Dihydro-6H-dipyrido [3,2-b:2',3'-e]diazepin-6-one und deren Verwendung in der Vorbeugung und Behandlung von AIDS.
AU2003220215A1 (en) Nk1 antagonists
WO2009138338A1 (en) Novel n-(2-amino-phenyl)-acrylamides
AU665825B2 (en) Novel amidoalkyl- and imidoalkyl-piperazines
HU195200B (en) Process for producing oxo-thiazolidine compounds and pharmaceutical preparations comprising the same
KR100305630B1 (ko) N-아미노알킬-2-안트라퀴논카르복스아미드:신규한도파민수용체서브타입특이적리간드
US4110472A (en) Derivatives of 1-(disubstituted phenoxy)-3-amino-2-hydroxypropanes
US6858640B2 (en) Tricyclic indole compounds having affinity for serotonin receptor
AU650375B2 (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
US5234934A (en) Aminopropanol derivatives, process for their preparation and pharmaceutical compositions comprising the same
US4965259A (en) Dioxazocine derivatives compositions and methods containing them having antidepressive, spasmolytic, anticonvulsive, and antiarrhythmic properties
US4029786A (en) Morpholine derivatives for treating depression
DK160299B (da) Basiske 2-fenylenmetylen-cykloalkanoximaetere eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8804688-3

Format of ref document f/p: F